Literature DB >> 9807669

The nitric oxide system and cortisol-induced hypertension in humans.

J J Kelly1, S H Tam, P M Williamson, J Lawson, J A Whitworth.   

Abstract

1. The aim of the present study was to assess the role of the nitric oxide (NO) system in cortisol-induced hypertension in humans. 2. Plasma and urinary nitrate/nitrite concentrations and plasma concentrations of arginine and symmetric (SDMA) and asymmetric (ADMA) dimethyl arginine were measured in six subjects on a restricted nitrate diet who were treated with 80 mg/day cortisol and in subjects on an unrestricted nitrate diet who were treated with cortisol (80 mg/day, n = 6, or 200 mg/day, n = 10) for 5 days. 3. Cortisol significantly increased systolic and mean arterial pressure. Significant reductions in plasma nitrate/nitrite concentrations were observed in subjects on a restricted nitrate diet on days 3, 4 and 5 of cortisol treatment (to 11 +/- 1, 10 +/- 1, 11 +/- 1 pmol/L, respectively) compared with pretreatment (16 +/- 1 pmol/L; P < 0.01). There were no significant changes in plasma arginine, ADMA or SDMA concentrations. 4. Cortisol treatment significantly increased blood pressure and reduced plasma nitrate/nitrite concentrations. Reductions in plasma nitrate concentrations are not explained by changes in substrate availability or in endogenous nitric oxide synthase inhibitors. These data support a role for the NO system in cortisol-induced hypertension in humans.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9807669     DOI: 10.1111/j.1440-1681.1998.tb02349.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  8 in total

1.  The role of sustained release isosorbide mononitrate on corticosteroid-induced hypertension in healthy human subjects.

Authors:  P M Williamson; S L H Ong; J A Whitworth; J J Kelly
Journal:  J Hum Hypertens       Date:  2015-03-26       Impact factor: 3.012

2.  Influence of Bcl-1 Gene Polymorphism of Glucocorticoid Receptor Gene (NR3C1, rs41423247) on Blood Pressure, Glucose in Northern Indians.

Authors:  Neena Srivastava; Jai Prakash; Ram Lakhan; C G Agarwal; D C Pant; Balraj Mittal
Journal:  Indian J Clin Biochem       Date:  2011-01-13

Review 3.  Psychobiology of depression/distress in congestive heart failure.

Authors:  Kaki M York; Mustafa Hassan; David S Sheps
Journal:  Heart Fail Rev       Date:  2008-03-27       Impact factor: 4.214

Review 4.  Cardiovascular risk and mortality in patients with active and treated hypercortisolism.

Authors:  Dingfeng Li; Omar M El Kawkgi; Andres F Henriquez; Irina Bancos
Journal:  Gland Surg       Date:  2020-02

5.  Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review.

Authors:  Melpomeni Peppa; Maria Krania; Sotirios A Raptis
Journal:  Integr Blood Press Control       Date:  2011-03-03

Review 6.  Cardiovascular consequences of cortisol excess.

Authors:  Judith A Whitworth; Paula M Williamson; George Mangos; John J Kelly
Journal:  Vasc Health Risk Manag       Date:  2005

Review 7.  The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.

Authors:  Andrea M Isidori; Chiara Graziadio; Rosa Maria Paragliola; Alessia Cozzolino; Alberto G Ambrogio; Annamaria Colao; Salvatore M Corsello; Rosario Pivonello
Journal:  J Hypertens       Date:  2015-01       Impact factor: 4.844

Review 8.  Buddhist meditation for vascular function: A narrative review.

Authors:  Anjalee Thanuja Amarasekera; Dennis Chang
Journal:  Integr Med Res       Date:  2019-11-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.